Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs MDxHealth SA (MDXH)

Advanced Biomed Inc. and MDxHealth SA are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $14.4M against $3.1M — 4.6× the size. MDxHealth SA has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −32.5%) and the lower return on invested capital (−33.4% vs −23.8%). Across the 12 metrics below, Advanced Biomed Inc. leads on 7 and MDxHealth SA on 5.

Valuation

Metric ADVB MDXH Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m 0.07 4.24
P/B 0.20 n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales n/m 0.81 5.18
Earnings yield 300.76% (480.00%) (1.50%)
Free cash flow yield (185.35%) (88.89%) 0.00%

Profitability

Metric ADVB MDXH Diagnostics & Research median
Gross margin — 63.23% 48.32%
Operating margin 0.00% (18.04%) (5.68%)
Net margin 0.00% (32.53%) (4.10%)
Free cash flow margin 0.00% (5.24%) 0.00%
Return on equity 84.77% 238.67% 0.00%
Return on assets 36.47% (27.38%) (6.05%)
Return on invested capital (33.43%) (23.77%) 0.00%

Growth

Metric ADVB MDXH Diagnostics & Research median
Revenue growth (TTM) — 21.46% 8.99%
EPS growth (last fiscal year) 266.56% 42.24% 20.36%
Revenue growth, 5-year CAGR — 42.34% 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB MDXH Diagnostics & Research median
Debt to equity 0.00 (3.42) 0.01
Current ratio 9.33 1.15 2.27
Net debt to EBITDA 0.06 (10.71) 0.68

Dividend

Metric ADVB MDXH Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB MDXH Diagnostics & Research median
Market cap 3.14m 14.40m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack